Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...
The aim of this study was to compare the results of the C-peptide response to mixed-meal stimulation in LADA patients with different disease durations and subjects with type 2 and adult-onset type ...
Hosted on MSN21h
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In ExcitementSana Biotechnology Inc.'s stock soared over 200% on Wednesday, on track to mark its best day on record, amid trading volumes ...
For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...
We reviewed hundreds of skin care and makeup products to bring you the best of Shop TODAY's 2024 Beauty Awards. From skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback